Clover Biopharmaceuticals, Ltd. (2197.HK)
HKD 0.26
(0.0%)
HKD 0.26
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 696.97 Million CNY | -70.77% |
| 2022 | 2.38 Billion CNY | 210.18% |
| 2021 | 768.69 Million CNY | 1410.76% |
| 2020 | 50.88 Million CNY | 12846.82% |
| 2019 | 393 Thousand CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 696.73 Million CNY | -0.04% |
| 2024 Q2 | 696.73 Million CNY | 0.0% |
| 2023 Q4 | 696.97 Million CNY | 0.0% |
| 2023 FY | 696.97 Million CNY | -70.77% |
| 2023 Q3 | 696.97 Million CNY | -40.38% |
| 2023 Q2 | 1.16 Billion CNY | 0.0% |
| 2023 Q1 | 1.16 Billion CNY | -50.97% |
| 2022 Q2 | 1.53 Billion CNY | 0.0% |
| 2022 Q1 | 1.53 Billion CNY | 99.88% |
| 2022 FY | 2.38 Billion CNY | 210.18% |
| 2022 Q4 | 2.38 Billion CNY | 0.0% |
| 2022 Q3 | 2.38 Billion CNY | 55.18% |
| 2021 FY | 768.69 Million CNY | 1410.76% |
| 2021 Q1 | 146.71 Million CNY | 0.0% |
| 2021 Q3 | 768.69 Million CNY | 0.0% |
| 2021 Q4 | 768.69 Million CNY | 0.0% |
| 2020 FY | 50.88 Million CNY | 12846.82% |
| 2019 FY | 393 Thousand CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 36.39 Million HKD | -1815.196% |
| CK Life Sciences Int'l., (Holdings) Inc. | 1.2 Billion HKD | 42.137% |